Albellar, Mark Lloyd S.
HRN: 07-58-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2022
CEFTRIAXONE 1G (VIAL)
05/08/2022
05/15/2022
IV
2g
Od
Asa:ap
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes